{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T23:09:33Z","timestamp":1792796973681,"version":"4.5.0"},"reference-count":146,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,16]],"date-time":"2023-05-16T00:00:00Z","timestamp":1684195200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009703","name":"Fondazione per la Ricerca Biomedica","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009703","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009882","name":"Regione Lombardia","doi-asserted-by":"publisher","award":["CP2_10\/2018"],"award-info":[{"award-number":["CP2_10\/2018"]}],"id":[{"id":"10.13039\/501100009882","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009882","name":"Regione Lombardia","doi-asserted-by":"publisher","award":["POR FESR 2526393 FORCE-4-CURE"],"award-info":[{"award-number":["POR FESR 2526393 FORCE-4-CURE"]}],"id":[{"id":"10.13039\/501100009882","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.phrs.2023.106796","type":"journal-article","created":{"date-parts":[[2023,5,17]],"date-time":"2023-05-17T22:25:00Z","timestamp":1684362300000},"page":"106796","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["New therapeutic approaches in pediatric diseases: Mesenchymal stromal cell and mesenchymal stromal cell-derived extracellular vesicles as new drugs"],"prefix":"10.1016","volume":"192","author":[{"given":"Chiara","family":"Valsecchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Croce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Lenta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria","family":"Acquafredda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"Comoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Antonietta","family":"Avanzini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.phrs.2023.106796_bib1","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1053\/j.semperi.2015.12.002","article-title":"Stem cell-based therapies for the newborn lung and brain: possibilities and challenges","volume":"40","author":"Mitsialis","year":"2016","journal-title":"Semin Perinatol."},{"issue":"5","key":"10.1016\/j.phrs.2023.106796_bib2","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1136\/thoraxjnl-2012-202323","article-title":"Short-term, long-term and paracrine effect of human umbilical cord-derived stem cells in lung injury prevention and repair in experimental bronchopulmonary dysplasia","volume":"68","author":"Pierro","year":"2013","journal-title":"Thorax"},{"key":"10.1016\/j.phrs.2023.106796_bib3","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ceb.2015.04.013","article-title":"Extracellular vesicles shuffling intercellular messages: for good or for bad","volume":"35","author":"Lo Cicero","year":"2015","journal-title":"Curr. Opin. Cell Biol."},{"issue":"4","key":"10.1016\/j.phrs.2023.106796_bib4","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/nrm.2017.125","article-title":"Shedding light on the cell biology of extracellular vesicles","volume":"19","author":"van","year":"2018","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.phrs.2023.106796_bib5","doi-asserted-by":"crossref","unstructured":"F. Lesage, B. Th\u00e9baud, Mesenchymal Stromal Cell-Derived Extracellular Vesicles for Neonatal Lung Disease: Tiny Particles, Major Promise, Rigorous Requirements for Clinical Translation, Cells. https:\/\/ , 2022\u00a01176. doi: 10.3390\/cells11071176.","DOI":"10.3390\/cells11071176"},{"issue":"3","key":"10.1016\/j.phrs.2023.106796_bib6","first-page":"381","article-title":"Osteogenesis in transplants of bone marrow cells","volume":"16","author":"Friedenstein","year":"1966","journal-title":"J. Embryol. Exp. Morphol."},{"issue":"1","key":"10.1016\/j.phrs.2023.106796_bib7","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/8756-3282(92)90364-3","article-title":"Characterization of cells with osteogenic potential from human marrow","volume":"13","author":"Haynesworth","year":"1992","journal-title":"Bone"},{"key":"10.1016\/j.phrs.2023.106796_bib8","doi-asserted-by":"crossref","unstructured":"S.H. Hong, E.J. Gang, J.A. Jeong, C. Ahn, S.H. Hwang, I.H. Yang, H.K. Park, H. Han, H. Kim, In vitro differentiation of human umbilical cord blood-derived mesenchymal stem cells into hepatocyte-like cells, Biochem Biophys Res Commun. 330(4) (2005) 1153\u201361. https:\/\/doi: 10.1016\/j.bbrc.2005.03.086.","DOI":"10.1016\/j.bbrc.2005.03.086"},{"issue":"4","key":"10.1016\/j.phrs.2023.106796_bib9","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/MPH.0b013e31816356e3","article-title":"Biologic characteristics of mesenchymal stromal cells and their clinical applications in pediatric patients","volume":"30","author":"Pelagiadis","year":"2008","journal-title":"J. Pedia Hematol. Oncol."},{"issue":"5","key":"10.1016\/j.phrs.2023.106796_bib10","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1080\/14653240500319234","article-title":"International society for cellular therapy. clarification of the nomenclature for MSC: the international society for cellular therapy position statement","volume":"7","author":"Horwitz","year":"2005","journal-title":"Cytotherapy"},{"issue":"4","key":"10.1016\/j.phrs.2023.106796_bib11","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/14653240600855905","article-title":"Minimal criteria for defining multipotent mesenchymal stromal cells. the international society for cellular therapy position statement","volume":"8","author":"Dominici","year":"2006","journal-title":"Cytotherapy"},{"issue":"2","key":"10.1016\/j.phrs.2023.106796_bib12","doi-asserted-by":"crossref","DOI":"10.1007\/BF02256058","article-title":"Characterization and functionality of cell surface molecules on human mesenchymal stem cells","volume":"10","author":"Majumdar","year":"2003","journal-title":"J. Biomed. Sci."},{"issue":"4","key":"10.1016\/j.phrs.2023.106796_bib13","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.stem.2013.09.006","article-title":"Mesenchymal stromal cells: sensors and switchers of inflammation","volume":"13","author":"Bernardo","year":"2013","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.phrs.2023.106796_bib14","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.3389\/fimmu.2017.01042","article-title":"Inflammatory conditions dictate the effect of mesenchymal stem or stromal cells on B cell function","volume":"8","author":"Luk","year":"2017","journal-title":"Front. Immunol."},{"issue":"10","key":"10.1016\/j.phrs.2023.106796_bib15","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/j.jcyt.2017.07.001","article-title":"Interaction of multipotent mesenchymal stromal and immune cells: bidirectional effects","volume":"19","author":"Andreeva","year":"2017","journal-title":"Cytotherapy"},{"issue":"7","key":"10.1016\/j.phrs.2023.106796_bib16","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.3390\/cells10071729","article-title":"The role of MSC in wound healing, scarring and regeneration","volume":"10","author":"Guillamat-Prats","year":"2021","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.phrs.2023.106796_bib17","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1007\/s10517-005-0430-z","article-title":"Mesenchymal stem cells from human bone marrow and adipose tissue: isolation, characterization, and differentiation potentialities","volume":"140","author":"Romanov","year":"2005","journal-title":"Bull. Exp. Biol. Med"},{"issue":"4","key":"10.1016\/j.phrs.2023.106796_bib18","doi-asserted-by":"crossref","DOI":"10.1007\/s10517-005-0331-1","article-title":"Comparison of mesenchymal stem cells obtained from different human tissues","volume":"139","author":"Musina","year":"2005","journal-title":"Bull. Exp. Biol. Med"},{"issue":"2","key":"10.1016\/j.phrs.2023.106796_bib19","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1006\/exnr.2000.7389","article-title":"Adult bone marrow stromal cells differentiate into neural cells in vitro","volume":"164","author":"Sanchez-Ramos","year":"2000","journal-title":"Exp. Neurol."},{"issue":"2","key":"10.1016\/j.phrs.2023.106796_bib20","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1046\/j.1365-2141.2003.04284.x","article-title":"Adult bone marrow is a rich source of human mesenchymal 'stem' cells but umbilical cord and mobilized adult blood are not","volume":"121","author":"Wexler","year":"2003","journal-title":"Br. J. Haematol."},{"issue":"6","key":"10.1016\/j.phrs.2023.106796_bib21","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1186\/ar130","article-title":"Mesenchymal precursor cells in the blood of normal individuals","volume":"2","author":"Zvaifler","year":"2000","journal-title":"Arthritis Res"},{"issue":"2","key":"10.1016\/j.phrs.2023.106796_bib22","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.yexcr.2005.04.029","article-title":"Functional studies of mesenchymal stem cells derived from adult human adipose tissue","volume":"308","author":"Dicker","year":"2005","journal-title":"Exp. Cell Res"},{"key":"10.1016\/j.phrs.2023.106796_bib23","article-title":"Toward personalized cell therapies by using stem cells: seven relevant topics for safety and success in stem cell therapy","volume":"2012","author":"de S\u00e1 Silva","year":"2012","journal-title":"J. Biomed. Biotechnol."},{"issue":"3","key":"10.1016\/j.phrs.2023.106796_bib24","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1634\/stemcells.19-3-180","article-title":"Bone marrow stromal stem cells: nature, biology, and potential applications","volume":"19","author":"Bianco","year":"2001","journal-title":"Stem Cells"},{"issue":"2","key":"10.1016\/j.phrs.2023.106796_bib25","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1634\/stemcells.2004-0331","article-title":"Characterization of the optimal culture conditions for clinical scale production of human mesenchymal stem cells","volume":"24","author":"Sotiropoulou","year":"2006","journal-title":"Stem Cells"},{"issue":"1","key":"10.1016\/j.phrs.2023.106796_bib26","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/jcp.20911","article-title":"Optimization of in vitro expansion of human multipotent mesenchymal stromal cells for cell-therapy approaches: further insights in the search for a fetal calf serum substitute","volume":"211","author":"Bernardo","year":"2007","journal-title":"J. Cell Physiol."},{"issue":"7","key":"10.1016\/j.phrs.2023.106796_bib27","doi-asserted-by":"crossref","first-page":"220","DOI":"10.3390\/biomedicines8070220","article-title":"Inactivated platelet lysate supports the proliferation and immunomodulant characteristics of mesenchymal stromal cells in GMP culture conditions","volume":"8","author":"Mareschi","year":"2020","journal-title":"Biomedicines"},{"key":"10.1016\/j.phrs.2023.106796_bib28","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.915277","article-title":"Human platelet lysate as alternative of fetal bovine serum for enhanced human in vitro bone resorption and remodeling","volume":"13","author":"de Wildt","year":"2022","journal-title":"Front Immunol."},{"issue":"4","key":"10.1016\/j.phrs.2023.106796_bib29","first-page":"557","article-title":"Ex vivo expansion and subsequent infusion of human bone marrow-derived stromal progenitor cells (mesenchymal progenitor cells): implications for therapeutic use","volume":"16","author":"Lazarus","year":"1995","journal-title":"Bone Marrow Transpl."},{"issue":"14","key":"10.1016\/j.phrs.2023.106796_bib30","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.2217\/imt-2018-0099","article-title":"Mesenchymal stromal cells in the treatment of perianal fistulas in Crohn's disease","volume":"10","author":"Castro-Poceiro","year":"2018","journal-title":"Immunotherapy"},{"issue":"1","key":"10.1016\/j.phrs.2023.106796_bib31","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1093\/stcltm\/szab009","article-title":"Definition and characteristics of mesenchymal stromal cells in preclinical and clinical studies: a scoping review","volume":"11","author":"Renesme","year":"2022","journal-title":"Stem Cells Transl. Med"},{"issue":"3","key":"10.1016\/j.phrs.2023.106796_bib32","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/nbt.2816","article-title":"Mesenchymal stem cells: immune evasive, not immune privileged","volume":"32","author":"Ankrum","year":"2014","journal-title":"Nat. Biotechnol."},{"issue":"9","key":"10.1016\/j.phrs.2023.106796_bib33","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.jcyt.2013.02.010","article-title":"MSC committee of the international society for cellular therapy (ISCT). Immunological characterization of multipotent mesenchymal stromal cells--the international society for cellular therapy (ISCT) working proposal","volume":"15","author":"Krampera","year":"2013","journal-title":"Cytotherapy"},{"issue":"2","key":"10.1016\/j.phrs.2023.106796_bib34","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jcyt.2015.11.008","article-title":"International society for Cellular Therapy perspective on immune functional assays for mesenchymal stromal cells as potency release criterion for advanced phase clinical trials","volume":"18","author":"Galipeau","year":"2016","journal-title":"Cytotherapy"},{"key":"10.1016\/j.phrs.2023.106796_bib35","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.632717","article-title":"Therapeutic use of mesenchymal stromal cells: the need for inclusive characterization guidelines to accommodate all tissue sources and species","volume":"9","author":"Wright","year":"2021","journal-title":"Front Cell Dev. Biol."},{"issue":"22","key":"10.1016\/j.phrs.2023.106796_bib36","article-title":"Mesenchymal stem cell perspective: cell biology to clinical progress","volume":"4","author":"Pittenger","year":"2019","journal-title":"NPJ Regen. Med"},{"issue":"1","key":"10.1016\/j.phrs.2023.106796_bib37","first-page":"17","volume":"9","author":"Kabat","year":"2020","journal-title":"Trends mesenchymal Stem Cell Clin. Trials 2004-2018: Is. Effic. Optim. a Narrow dose range? Stem Cells Transl. Med"},{"issue":"12","key":"10.1016\/j.phrs.2023.106796_bib38","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/j.addr.2010.09.013","article-title":"Mesenchymal stem cells for the sustained in vivo delivery of bioactive factors","volume":"62","author":"Meyerrose","year":"2010","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"31","key":"10.1016\/j.phrs.2023.106796_bib39","doi-asserted-by":"crossref","first-page":"15392","DOI":"10.1073\/pnas.1819415116","article-title":"Programmable microencapsulation for enhanced mesenchymal stem cell persistence and immunomodulation","volume":"116","author":"Mao","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"11","key":"10.1016\/j.phrs.2023.106796_bib40","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1002\/sctm.19-0073","article-title":"Mesenchymal stromal cells anno 2019: dawn of the therapeutic era? concise review","volume":"8","author":"Hoogduijn","year":"2019","journal-title":"Stem Cells Transl. Med"},{"issue":"1","key":"10.1016\/j.phrs.2023.106796_bib41","doi-asserted-by":"crossref","first-page":"10142","DOI":"10.1038\/s41598-020-67039-w","article-title":"Mesenchymal stromal cell bioreactor for ex vivo reprogramming of human immune cells","volume":"10","author":"Allen","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.phrs.2023.106796_bib42","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.3389\/fimmu.2019.01645","article-title":"Mesenchymal stromal cell therapeutic delivery: translational challenges to clinical application","volume":"10","author":"Caplan","year":"2019","journal-title":"Front Immunol."},{"issue":"5","key":"10.1016\/j.phrs.2023.106796_bib43","first-page":"368","volume":"23","author":"Galipeau","year":"2021","journal-title":"Mesenchymal Strom. Cell Var. Influ. Clin. potency: Impact viability, Fit., Route Adm. host predisposition, Cytotherapy"},{"issue":"7","key":"10.1016\/j.phrs.2023.106796_bib44","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1161\/STROKEAHA.121.036545","article-title":"Circulating extracellular vesicles in stroke patients treated with mesenchymal stem cells: a biomarker analysis of a randomized trial","volume":"53","author":"Bang","year":"2022","journal-title":"Stroke"},{"issue":"2","key":"10.1016\/j.phrs.2023.106796_bib45","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/liv.15490","article-title":"Extracellular vesicles in fatty liver disease and steatohepatitis: role as biomarkers and therapeutic targets","volume":"43","author":"Eguchi","year":"2022","journal-title":"Liver Int"},{"issue":"1","key":"10.1016\/j.phrs.2023.106796_bib46","doi-asserted-by":"crossref","first-page":"1535750","DOI":"10.1080\/20013078.2018.1535750","article-title":"Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines","volume":"7","author":"Th\u00e9ry","year":"2018","journal-title":"J. Extra Vesicles"},{"key":"10.1016\/j.phrs.2023.106796_bib47","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1146\/annurev-cellbio-101512-122326","article-title":"Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles","volume":"30","author":"Colombo","year":"2014","journal-title":"Annu Rev. Cell Dev. Biol."},{"issue":"12","key":"10.1016\/j.phrs.2023.106796_bib48","doi-asserted-by":"crossref","first-page":"999","DOI":"10.3390\/diagnostics10120999","article-title":"Clinical applications of mesenchymal stem\/stromal cell derived extracellular vesicles: therapeutic potential of an acellular product","volume":"10","author":"Massa","year":"2020","journal-title":"Diagnostics"},{"issue":"1","key":"10.1016\/j.phrs.2023.106796_bib49","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1038\/s41467-020-14344-7","article-title":"Inhalation of lung spheroid cell secretome and exosomes promotes lung repair in pulmonary fibrosis","volume":"11","author":"Dinh","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.phrs.2023.106796_bib50","doi-asserted-by":"crossref","first-page":"5911","DOI":"10.2147\/IJN.S249129","article-title":"Umbilical cord-derived mesenchymal stem cell-derived exosomes combined pluronic F127 hydrogel promote chronic diabetic wound healing and complete skin regeneration","volume":"15","author":"Yang","year":"2020","journal-title":"Int J. Nanomed."},{"issue":"3","key":"10.1016\/j.phrs.2023.106796_bib51","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/nri3622","article-title":"Regulation of immune responses by extracellular vesicles","volume":"14","author":"Robbins","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.phrs.2023.106796_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2020.101106","article-title":"Mesenchymal stem cell-derived extracellular vesicle-based therapies protect against coupled degeneration of the central nervous and vascular systems in stroke","volume":"62","author":"Rahmani","year":"2020","journal-title":"Ageing Res Rev."},{"issue":"3","key":"10.1016\/j.phrs.2023.106796_bib53","volume":"5","author":"Horwitz","year":"1999","journal-title":"Transpl. Ther. Eff. Bone Marrow-Deriv. mesenchymal Cells Child. Osteogenes. imperfecta, Nat. Med"},{"issue":"13","key":"10.1016\/j.phrs.2023.106796_bib54","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.132252399","article-title":"Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implications for cell therapy of bone","volume":"99","author":"Horwitz","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"11","key":"10.1016\/j.phrs.2023.106796_bib55","doi-asserted-by":"crossref","DOI":"10.1097\/01.TP.0000159029.48678.93","article-title":"Fetal mesenchymal stem-cell engraftment in bone after in utero transplantation in a patient with severe osteogenesis imperfecta","volume":"79","author":"Le Blanc","year":"2005","journal-title":"Transplantation"},{"key":"10.1016\/j.phrs.2023.106796_bib56","doi-asserted-by":"crossref","first-page":"9652897","DOI":"10.1155\/2018\/9652897","article-title":"The potentials and caveats of mesenchymal stromal cell-based therapies in the preterm infant","volume":"2018","author":"Gronbach","year":"2018","journal-title":"Stem Cells Int"},{"issue":"12","key":"10.1016\/j.phrs.2023.106796_bib57","doi-asserted-by":"crossref","DOI":"10.1002\/sctm.17-0219","article-title":"Mesenchymal stem cells for severe intraventricular hemorrhage in preterm infants: phase I dose-escalation clinical trial","volume":"7","author":"Ahn","year":"2018","journal-title":"Stem Cells Transl. Med"},{"key":"10.1016\/j.phrs.2023.106796_bib58","article-title":"Bronchopulmonary dysplasia: executive summary of a workshop","volume":"197","author":"Higgins","year":"2018","journal-title":"J. Pedia"},{"issue":"1","key":"10.1016\/j.phrs.2023.106796_bib59","first-page":"5","article-title":"Characteristics and clinical applications of Wharton's jelly-derived mesenchymal stromal cells","volume":"68","author":"Liau","year":"2020","journal-title":"Curr. Res Transl. Med"},{"key":"10.1016\/j.phrs.2023.106796_bib60","doi-asserted-by":"crossref","first-page":"188","DOI":"10.3389\/fped.2020.00188","article-title":"Incidence, treatment, and outcome trends of necrotizing enterocolitis in preterm infants: a multicenter cohort study","volume":"8","author":"Zozaya","year":"2020","journal-title":"Front Pedia"},{"key":"10.1016\/j.phrs.2023.106796_bib61","doi-asserted-by":"crossref","DOI":"10.1159\/000497420","article-title":"Necrotizing enterocolitis, gut microbiota, and brain development: role of the brain-gut axis","volume":"115","author":"Niemarkt","year":"2019","journal-title":"Neonatology"},{"key":"10.1016\/j.phrs.2023.106796_bib62","article-title":"Stem cells as therapy for necrotizing enterocolitis: a systematic review and meta-analysis of preclinical studies","volume":"8","author":"Villamor-Martinez","year":"2020","journal-title":"Front Pedia"},{"issue":"6","key":"10.1016\/j.phrs.2023.106796_bib63","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.jpedsurg.2017.03.028","article-title":"Stem cells and necrotizing enterocolitis: a direct comparison of the efficacy of multiple types of stem cells","volume":"52","author":"McCulloh","year":"2017","journal-title":"J. Pedia Surg."},{"issue":"1","key":"10.1016\/j.phrs.2023.106796_bib64","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41390-021-01657-6","article-title":"Amniotic fluid stem cell administration can prevent epithelial injury from necrotizing enterocolitis","volume":"91","author":"Li","year":"2022","journal-title":"Pedia Res"},{"key":"10.1016\/j.phrs.2023.106796_bib65","article-title":"Dissecting paracrine effectors for mesenchymal stem cells","volume":"129","author":"Bruno","year":"2013","journal-title":"Adv. Biochem Eng. Biotechnol."},{"issue":"2","key":"10.1016\/j.phrs.2023.106796_bib66","doi-asserted-by":"crossref","DOI":"10.1016\/j.surg.2009.03.031","article-title":"Mesenchymal stem cells enhance the viability and proliferation of human fetal intestinal epithelial cells following hypoxic injury via paracrine mechanisms","volume":"146","author":"Weil","year":"2009","journal-title":"Surgery"},{"issue":"6","key":"10.1016\/j.phrs.2023.106796_bib67","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/j.jpedsurg.2018.02.086","article-title":"Treatment of experimental necrotizing enterocolitis with stem cell-derived exosomes","volume":"53","author":"McCulloh","year":"2018","journal-title":"J. Pedia Surg."},{"issue":"6","key":"10.1016\/j.phrs.2023.106796_bib68","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpedsurg.2016.02.061","article-title":"Exosomes secreted from bone marrow-derived mesenchymal stem cells protect the intestines from experimental necrotizing enterocolitis","volume":"51","author":"Rager","year":"2016","journal-title":"J. Pedia Surg."},{"issue":"3","key":"10.1016\/j.phrs.2023.106796_bib69","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.jpedsurg.2018.07.025","article-title":"Potential role of stem cells in disease prevention based on a murine model of experimental necrotizing enterocolitis","volume":"54","author":"Pisano","year":"2019","journal-title":"J. Pedia Surg."},{"issue":"3","key":"10.1016\/j.phrs.2023.106796_bib70","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1080\/15513815.2019.1693672","article-title":"Successful mesenchymal stem cell application in supraventricular tachycardia-related necrotizing enterocolitis: a case report","volume":"40","author":"Akduman","year":"2021","journal-title":"Fetal Pedia Pathol."},{"key":"10.1016\/j.phrs.2023.106796_bib71","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/MOP.0b013e3283423e6b","article-title":"The new bronchopulmonary dysplasia","volume":"23","author":"Jobe","year":"2011","journal-title":"Curr. Opin. Pedia"},{"issue":"4","key":"10.1016\/j.phrs.2023.106796_bib72","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2014-2651","article-title":"Lung function in very low birth weight adults","volume":"136","author":"Saarenp\u00e4\u00e4","year":"2015","journal-title":"Pediatrics"},{"key":"10.1016\/j.phrs.2023.106796_bib73","article-title":"Bronchopulmonary dysplasia: executive summary of a workshop","volume":"197","author":"Higgins","year":"2018","journal-title":"J. Pedia"},{"key":"10.1016\/j.phrs.2023.106796_bib74","article-title":"The potential of mesenchymal stromal cell as therapy in neonatal diseases","volume":"8","author":"Liau","year":"2020","journal-title":"Front Pedia"},{"issue":"6","key":"10.1016\/j.phrs.2023.106796_bib75","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1089\/scd.2019.0116","article-title":"Late rescue therapy with cord-derived mesenchymal stromal cells for established lung injury in experimental bronchopulmonary dysplasia","volume":"29","author":"O'Reilly","year":"2020","journal-title":"Stem Cells Dev."},{"issue":"8","key":"10.1016\/j.phrs.2023.106796_bib76","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1093\/stcltm\/szac041","article-title":"Mesenchymal stem cell-derived extracellular vesicles prevent experimental bronchopulmonary dysplasia complicated by pulmonary hypertension","volume":"11","author":"Sharma","year":"2022","journal-title":"Stem Cells Transl. Med"},{"issue":"5","key":"10.1016\/j.phrs.2023.106796_bib77","doi-asserted-by":"crossref","first-page":"L688","DOI":"10.1152\/ajplung.00148.2020","article-title":"Intratracheal administration of mesenchymal stem cell-derived extracellular vesicles reduces lung injuries in a chronic rat model of bronchopulmonary dysplasia","volume":"320","author":"Porzionato","year":"2021","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"issue":"1","key":"10.1016\/j.phrs.2023.106796_bib78","doi-asserted-by":"crossref","first-page":"L6","DOI":"10.1152\/ajplung.00109.2018","article-title":"Intratracheal administration of clinical-grade mesenchymal stem cell-derived extracellular vesicles reduces lung injury in a rat model of bronchopulmonary dysplasia","volume":"316","author":"Porzionato","year":"2019","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"issue":"1","key":"10.1016\/j.phrs.2023.106796_bib79","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1164\/rccm.201705-0925OC","article-title":"Mesenchymal stromal cell exosomes ameliorate experimental bronchopulmonary dysplasia and restore lung function through macrophage immunomodulation","volume":"197","author":"Willis","year":"2018","journal-title":"Am. J. Respir. Crit. Care Med"},{"issue":"12","key":"10.1016\/j.phrs.2023.106796_bib80","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1164\/rccm.202102-0329OC","article-title":"Extracellular vesicles protect the neonatal lung from hyperoxic injury through the epigenetic and transcriptomic reprogramming of myeloid cells","volume":"204","author":"Willis","year":"2021","journal-title":"Am. J. Respir. Crit. Care Med"},{"issue":"3\u20134","key":"10.1016\/j.phrs.2023.106796_bib81","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1089\/scd.2021.0256","article-title":"Mesenchymal stem cell-derived extracellular vesicles suppress hyperoxia-induced transdifferentiation of rat alveolar type 2 epithelial cells","volume":"31","author":"Ai","year":"2022","journal-title":"Stem Cells Dev"},{"issue":"23","key":"10.1016\/j.phrs.2023.106796_bib82","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1089\/scd.2020.0156","article-title":"Human umbilical cord mesenchymal stem cell-derived small extracellular vesicles alleviate lung injury in rat model of bronchopulmonary dysplasia by affecting cell survival and angiogenesis","volume":"29","author":"You","year":"2020","journal-title":"Stem Cells Dev."},{"key":"10.1016\/j.phrs.2023.106796_bib83","doi-asserted-by":"crossref","first-page":"8465294","DOI":"10.1155\/2022\/8465294","article-title":"Microvesicles derived from human umbilical cord mesenchymal stem cells enhance alveolar type II cell proliferation and attenuate lung inflammation in a rat model of bronchopulmonary dysplasia","volume":"2022","author":"Zhou","year":"2022","journal-title":"Stem Cells Int"},{"issue":"11","key":"10.1016\/j.phrs.2023.106796_bib84","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1016\/j.jcyt.2018.09.003","article-title":"Off-label mesenchymal stromal cell treatment in two infants with severe bronchopulmonary dysplasia: clinical course and biomarkers profile","volume":"20","author":"\u00c1lvarez-Fuente","year":"2018","journal-title":"Cytotherapy"},{"key":"10.1016\/j.phrs.2023.106796_bib85","doi-asserted-by":"crossref","unstructured":"S.B. Powell , J.M. Silvestri , Safety of Intratracheal Administration of Human Umbilical Cord Blood Derived Mesenchymal Stromal Cells in Extremely Low Birth Weight Preterm Infants, J Pediatr. 210 (2019) 209\u2013213.e2. https:\/\/ doi: 10.1016\/j.jpeds.2019.02.029.","DOI":"10.1016\/j.jpeds.2019.02.029"},{"issue":"1","key":"10.1016\/j.phrs.2023.106796_bib86","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1186\/s12967-020-02568-6","article-title":"Allogeneic administration of human umbilical cord-derived mesenchymal stem\/stromal cells for bronchopulmonary dysplasia: preliminary outcomes in four Vietnamese infants","volume":"18","author":"Nguyen","year":"2020","journal-title":"J. Transl. Med"},{"key":"10.1016\/j.phrs.2023.106796_bib87","doi-asserted-by":"crossref","DOI":"10.1177\/2155179018759434","article-title":"Airway delivery of bone marrow-derived mesenchymal stem cells reverses bronchopulmonary dysplasia superimposed with acute respiratory distress syndrome in an infant","volume":"10","author":"Lin","year":"2018","journal-title":"Cell Med"},{"issue":"4","key":"10.1016\/j.phrs.2023.106796_bib88","first-page":"425","article-title":"The clinical and radiological course of bronchopulmonary dysplasia in twins treated with mesenchymal stem cells and followed up using lung ultrasonography","volume":"55","author":"\u00d6ktem","year":"2020","journal-title":"Turk. Pediatri Ars"},{"issue":"12","key":"10.1016\/j.phrs.2023.106796_bib89","doi-asserted-by":"crossref","first-page":"3270","DOI":"10.3390\/cells10123270","article-title":"Mesenchymal stromal cells for the treatment of interstitial lung disease in children: a look from pediatric and pediatric surgeon viewpoints","volume":"10","author":"Pelizzo","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.phrs.2023.106796_bib90","doi-asserted-by":"crossref","unstructured":"G. Pelizzo , M.A. Avanzini , E. Lenta , M. Mantelli , S. Croce , L. Catenacci , G. Acquafredda , A.L. Ferraro , C. Giambanco , L. D'Amelio , S. Giordano , G. Re , F. Zennaro , V. Calcaterra , Allogeneic mesenchymal stromal cells: Novel therapeutic option for mutated FLNA-associated respiratory failure in the pediatric setting, Pediatr Pulmonol. 55(1) (2020) 190\u2013197. https:\/\/doi: 10.1002\/ppul.24497.","DOI":"10.1002\/ppul.24497"},{"issue":"6","key":"10.1016\/j.phrs.2023.106796_bib91","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1212\/WNL.59.6.824","article-title":"A prospective, longitudinal diffusion tensor imaging study of brain injury in newborns","volume":"59","author":"McKinstry","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.phrs.2023.106796_bib92","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2017-4164","article-title":"Neurodevelopment after perinatal arterial ischemic stroke","author":"Wagenaar","year":"2018","journal-title":"Pediatrics"},{"key":"10.1016\/j.phrs.2023.106796_bib93","first-page":"8","article-title":"A report: the definition and classification of cerebral palsy April 2006","volume":"109","author":"Rosenbaum","year":"2007","journal-title":"Dev. Med Child Neurol. Suppl."},{"issue":"10","key":"10.1016\/j.phrs.2023.106796_bib94","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1111\/dmcn.13528","article-title":"Repair of neonatal brain injury: bringing stem cell-based therapy into clinical practice","volume":"59","author":"Wagenaar","year":"2017","journal-title":"Dev. Med Child Neurol."},{"key":"10.1016\/j.phrs.2023.106796_bib95","doi-asserted-by":"crossref","first-page":"207","DOI":"10.3389\/fncel.2014.00207","article-title":"Stem cells for neonatal stroke- the future is here","volume":"8","author":"van Velthoven","year":"2014","journal-title":"Front Cell Neurosci."},{"issue":"5","key":"10.1016\/j.phrs.2023.106796_bib96","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1002\/jnr.23954","article-title":"Mesenchymal stem cells attenuate MRI-identifiable injury, protect white matter, and improve long-term functional outcomes after neonatal focal stroke in rats","volume":"95","author":"van Velthoven","year":"2017","journal-title":"J. Neurosci. Res"},{"issue":"1","key":"10.1016\/j.phrs.2023.106796_bib97","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1161\/STROKEAHA.120.031191","article-title":"Enhanced mesenchymal stromal cells or erythropoietin provide long-term functional benefit after neonatal stroke","volume":"52","author":"Larpthaveesarp","year":"2021","journal-title":"Stroke"},{"key":"10.1016\/j.phrs.2023.106796_bib98","doi-asserted-by":"crossref","first-page":"133","DOI":"10.3389\/fneur.2018.00133","article-title":"Dose-dependent effect of intravenous administration of human umbilical cord-derived mesenchymal stem cells in neonatal stroke mice","volume":"9","author":"Tanaka","year":"2018","journal-title":"Front Neurol."},{"key":"10.1016\/j.phrs.2023.106796_bib99","doi-asserted-by":"crossref","unstructured":"Z.G. Zhang , B. Buller , M. Chopp Exosomes - beyond stem cells for restorative therapy in stroke and neurological injury, Nature reviews Neurology. 15(4) (2019) 193\u2013203. https:\/\/doi: 10.1038\/s41582\u2013018-0126\u20134.","DOI":"10.1038\/s41582-018-0126-4"},{"issue":"3","key":"10.1016\/j.phrs.2023.106796_bib100","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1007\/s13311-021-01076-9","article-title":"(MSC)-derived extracellular vesicles protect from neonatal stroke by interacting with microglial cells","volume":"18","author":"Pathipati","year":"2021","journal-title":"Neurotherapeutics"},{"issue":"6","key":"10.1016\/j.phrs.2023.106796_bib101","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/S1474-4422(22)00117-X","article-title":"Feasibility and safety of intranasally administered mesenchymal stromal cells after perinatal arterial ischaemic stroke in the Netherlands (PASSIoN): a first-in-human, open-label intervention study","volume":"21","author":"Baak","year":"2022","journal-title":"Lancet Neurol."},{"issue":"2","key":"10.1016\/j.phrs.2023.106796_bib102","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1177\/0963689717729379","article-title":"A randomized, placebo-controlled trial of human umbilical cord blood mesenchymal stem cell infusion for children with cerebral palsy","volume":"27","author":"Huang","year":"2018","journal-title":"Cell Transpl."},{"issue":"1","key":"10.1016\/j.phrs.2023.106796_bib103","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1186\/s13287-021-02513-4","article-title":"Clinical and imaging outcomes after intrathecal injection of umbilical cord tissue mesenchymal stem cells in cerebral palsy: a randomized double-blind sham-controlled clinical trial","volume":"12","author":"Amanat","year":"2021","journal-title":"Stem Cell Res Ther."},{"key":"10.1016\/j.phrs.2023.106796_bib104","doi-asserted-by":"crossref","unstructured":"J.P. Abbuehl , Z. Tatarova , W. Held , J. . Huelsken . Long-Term Engraftment of Primary Bone Marrow Stromal Cells Repairs Niche Damage and Improves Hematopoietic Stem Cell Transplantation, Cell Stem Cell. 21(2) (2017) 241\u2013255.e6. https:\/\/doi: 10.1016\/j.stem.2017.07.004.","DOI":"10.1016\/j.stem.2017.07.004"},{"issue":"6","key":"10.1016\/j.phrs.2023.106796_bib105","doi-asserted-by":"crossref","DOI":"10.1097\/01.moh.0000245697.54887.6f","article-title":"Mesenchymal stromal cells","volume":"13","author":"Keating","year":"2006","journal-title":"Curr. Opin. Hematol."},{"issue":"2","key":"10.1016\/j.phrs.2023.106796_bib106","doi-asserted-by":"crossref","DOI":"10.1016\/j.stem.2008.01.007","article-title":"How do mesenchymal stromal cells suppress T cells?","volume":"2","author":"Keating","year":"2008","journal-title":"Cell Stem Cell"},{"issue":"9","key":"10.1016\/j.phrs.2023.106796_bib107","article-title":"Mesenchymal stem cells health","volume":"8","author":"Uccelli","year":"2008","journal-title":"Dis. Nat. Rev. Immunol."},{"issue":"8","key":"10.1016\/j.phrs.2023.106796_bib108","doi-asserted-by":"crossref","DOI":"10.1002\/stem.459","article-title":"Concise review: hitting the right spot with mesenchymal stromal cells","volume":"28","author":"Tolar","year":"2010","journal-title":"Stem Cells"},{"issue":"10","key":"10.1016\/j.phrs.2023.106796_bib109","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V99.10.3838","article-title":"Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli","volume":"99","author":"Di Nicola","year":"2002","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.phrs.2023.106796_bib110","article-title":"Immunomodulatory","volume":"5","author":"Le Blanc","year":"2003","journal-title":"Eff. Fetal adult mesenchymal stem Cells Cytotherapy"},{"issue":"6","key":"10.1016\/j.phrs.2023.106796_bib111","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/sj.bmt.1704400","article-title":"Human mesenchymal stem cells support unrelated donor hematopoietic stem cells and suppress T-cell activation","volume":"33","author":"Maitra","year":"2004","journal-title":"Bone Marrow Transpl."},{"issue":"21","key":"10.1016\/j.phrs.2023.106796_bib112","doi-asserted-by":"crossref","DOI":"10.1038\/gt.2008.101","article-title":"Cancer gene therapy using mesenchymal stem cells expressing interferon-beta in a mouse prostate cancer lung metastasis model","volume":"15","author":"Ren","year":"2008","journal-title":"Gene Ther."},{"issue":"3","key":"10.1016\/j.phrs.2023.106796_bib113","article-title":"Mesenchymal strom","volume":"22","author":"Tolar","year":"2011","journal-title":"Cells graft-Versus-host Dis. Hum. Gene Ther."},{"issue":"1","key":"10.1016\/j.phrs.2023.106796_bib114","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/s13045-018-0680-7","article-title":"A potent immunomodulatory role of exosomes derived from mesenchymal stromal cells in preventing cGVHD","volume":"11","author":"Lai","year":"2018","journal-title":"J. Hematol. Oncol."},{"issue":"5","key":"10.1016\/j.phrs.2023.106796_bib115","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.jcyt.2018.02.372","article-title":"Mesenchymal stromal cell exosome-enhanced regulatory T-cell production through an antigen-presenting cell-mediated pathway","volume":"20","author":"Zhang","year":"2018","journal-title":"Cytotherapy"},{"issue":"24","key":"10.1016\/j.phrs.2023.106796_bib116","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1089\/scd.2016.0107","article-title":"Extracellular vesicles released from human umbilical cord-derived mesenchymal stromal cells prevent life-threatening acute graft-versus-host disease in a mouse model of allogeneic hematopoietic stem cell transplantation","volume":"25","author":"Wang","year":"2016","journal-title":"Stem Cells Dev."},{"issue":"5","key":"10.1016\/j.phrs.2023.106796_bib117","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1002\/stem.3160","article-title":"Functional dosing of mesenchymal stromal cell-derived extracellular vesicles for the prevention of acute graft-versus-host-disease","volume":"38","author":"Dal Collo","year":"2020","journal-title":"Stem Cells"},{"issue":"9624","key":"10.1016\/j.phrs.2023.106796_bib118","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/S0140-6736(08)60690-X","article-title":"Developmental committee of the European Group for blood and marrow transplantation mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study","volume":"371","author":"Le Blanc","year":"2008","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.phrs.2023.106796_bib119","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/bjh.12545","article-title":"Multiple infusions of mesenchymal stromal cells induce sustained remission in children with steroid-refractory, grade III-IV acute graft-versus-host disease","volume":"163","author":"Ball","year":"2013","journal-title":"Br. J. Haematol."},{"issue":"2","key":"10.1016\/j.phrs.2023.106796_bib120","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.bbmt.2013.11.001","article-title":"Allogeneic human mesenchymal stem cell therapy (remestemcel-L, Prochymal) as a rescue agent for severe refractory acute graft-versus-host disease in pediatric patients","volume":"20","author":"Kurtzberg","year":"2014","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"22","key":"10.1016\/j.phrs.2023.106796_bib121","doi-asserted-by":"crossref","first-page":"5877","DOI":"10.1182\/bloodadvances.2020002646","article-title":"Mesenchymal stromal cells in hematopoietic cell transplantation","volume":"4","author":"Burnham","year":"2020","journal-title":"Blood Adv."},{"key":"10.1016\/j.phrs.2023.106796_bib122","article-title":"Current prophylaxis and treatment approaches for acute graft-versus-host disease in haematopoietic stem cell transplantation for children with acute lymphoblastic leukaemia","volume":"9","author":"W\u00f6lfl","year":"2022","journal-title":"Front Pedia"},{"issue":"5","key":"10.1016\/j.phrs.2023.106796_bib123","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.bbmt.2020.01.018","volume":"26","author":"Kurtzberg","year":"2020","journal-title":"Biol. Blood Marrow Transpl."},{"key":"10.1016\/j.phrs.2023.106796_bib124","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.839844","article-title":"Mesenchymal stromal cells for enhancing hematopoietic engraftment and treatment of graft-versus-host disease, hemorrhages and acute respiratory distress syndrome","volume":"13","author":"Ringd\u00e9n","year":"2022","journal-title":"Front Immunol."},{"key":"10.1016\/j.phrs.2023.106796_bib125","doi-asserted-by":"crossref","DOI":"10.1038\/bmt.2008.348","article-title":"Transplantation of exvivo culture-expanded parental haploidentical mesenchymal stem cells to promote engraftment in pediatric recipients of unrelated donor umbilical cord blood: results of a phase I-II clinical trial","volume":"43","author":"Macmillan","year":"2009","journal-title":"Bone Marrow Transpl."},{"key":"10.1016\/j.phrs.2023.106796_bib126","article-title":"Cotransplantation of ex vivo expanded mesenchymal stem cells accelerates lymphocyte recovery and may reduce the risk of graft failure in haploidentical hematopoietic stem-cell transplantation","volume":"110","author":"Ball","year":"2007","journal-title":"Blood"},{"issue":"7\u20138","key":"10.1016\/j.phrs.2023.106796_bib127","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1089\/scd.2021.0352","article-title":"Hematopoietic stem cell transplantation with mesenchymal stromal cells in children with metachromatic leukodystrophy","volume":"31","author":"Cabanillas Stanchi","year":"2022","journal-title":"Stem Cells Dev."},{"issue":"10","key":"10.1016\/j.phrs.2023.106796_bib128","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2004-02-0586","article-title":"Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells","volume":"105","author":"Jiang","year":"2005","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.phrs.2023.106796_bib129","doi-asserted-by":"crossref","DOI":"10.1634\/stemcells.2007-0416","article-title":"Human mesenchymal stem cells inhibit neutrophil apoptosis: a model for neutrophil preservation in the bone marrow niche","volume":"26","author":"Raffaghello","year":"2008","journal-title":"Stem Cells"},{"issue":"1","key":"10.1016\/j.phrs.2023.106796_bib130","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jaut.2008.10.004","article-title":"Autologous bone marrow-derived rat mesenchymal stem cells promote PDX-1 and insulin expression in the islets, alter T cell cytokine pattern and preserve regulatory T cells in the periphery and induce sustained normoglycemia","volume":"32","author":"Boumaza","year":"2009","journal-title":"J. Autoimmun."},{"issue":"5","key":"10.1016\/j.phrs.2023.106796_bib131","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.stemcr.2017.04.008","article-title":"MSC-derived extracellular vesicles attenuate immune responses in two autoimmune murine models: type 1 diabetes and uveoretinitis","volume":"8","author":"Shigemoto-Kuroda","year":"2017","journal-title":"Stem Cell Rep."},{"issue":"2","key":"10.1016\/j.phrs.2023.106796_bib132","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1007\/s40200-020-00647-5","article-title":"Therapeutic potential of mesenchymal stem cells in treating both types of diabetes mellitus and associated diseases","volume":"19","author":"Goenka","year":"2020","journal-title":"J. Diabetes Metab. Disord."},{"issue":"2","key":"10.1016\/j.phrs.2023.106796_bib133","doi-asserted-by":"crossref","DOI":"10.1007\/s00125-015-3808-0","article-title":"Human mesenchymal stem cells and derived extracellular vesicles induce regulatory dendritic cells in type 1 diabetic patients","volume":"59","author":"Favaro","year":"2016","journal-title":"Diabetologia"},{"issue":"11","key":"10.1016\/j.phrs.2023.106796_bib134","doi-asserted-by":"crossref","first-page":"9433","DOI":"10.1002\/jcb.27260","article-title":"Immunomodulatory effects of mesenchymal stem cell-derived exosomes on experimental type-1 autoimmune diabetes","volume":"119","author":"Nojehdehi","year":"2018","journal-title":"J. Cell Biochem"},{"issue":"1","key":"10.1016\/j.phrs.2023.106796_bib135","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1186\/s13287-022-02941-w","article-title":"Mesenchymal stem cell transplantation in newly diagnosed type-1 diabetes patients: a phase I\/II randomized placebo-controlled clinical trial","volume":"13","author":"Izadi","year":"2022","journal-title":"Stem Cell Res Ther."},{"issue":"3","key":"10.1016\/j.phrs.2023.106796_bib136","doi-asserted-by":"crossref","DOI":"10.1038\/nbt.2816","article-title":"Mesenchymal stem cells: immune evasive, not immune privileged","volume":"32","author":"Ankrum","year":"2014","journal-title":"Nat. Biotechnol."},{"issue":"7","key":"10.1016\/j.phrs.2023.106796_bib137","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcyt.2013.03.005","article-title":"Risk of tumorigenicity in mesenchymal stromal cell-based therapies--bridging scientific observations and regulatory viewpoints","volume":"15","author":"Barkholt","year":"2013","journal-title":"Cytotherapy"},{"issue":"4","key":"10.1016\/j.phrs.2023.106796_bib138","doi-asserted-by":"crossref","first-page":"389","DOI":"10.5966\/sctm.2014-0110","article-title":"Concise review: workshop review: understanding and assessing the risks of stem cell-based therapies","volume":"4","author":"Heslop","year":"2015","journal-title":"Stem Cells Transl. Med"},{"issue":"1","key":"10.1016\/j.phrs.2023.106796_bib139","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0087238","article-title":"Allo-reactivity of mesenchymal stem cells in rhesus macaques is dose and haplotype dependent and limits durable cell engraftment in vivo","volume":"9","author":"Isakova","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.phrs.2023.106796_bib140","doi-asserted-by":"crossref","DOI":"10.1002\/stem.727","article-title":"Concise review: Induced pluripotent stem cell-derived mesenchymal stem cells: progress toward safe clinical products","volume":"30","author":"Jung","year":"2012","journal-title":"Stem Cells"},{"key":"10.1016\/j.phrs.2023.106796_bib141","doi-asserted-by":"crossref","unstructured":"P. Vader , E.A. Mol , G. Pasterkamp , R.M. Schiffelers . Extracellular vesicles for drug delivery. Adv Drug Deliv Rev. 106(PtA) (2016) 148\u2013156. doi: 10.1016\/j.addr.2016.02.006.","DOI":"10.1016\/j.addr.2016.02.006"},{"issue":"11","key":"10.1016\/j.phrs.2023.106796_bib142","doi-asserted-by":"crossref","DOI":"10.1158\/0008-5472.CAN-10-4455","article-title":"Exosomes released by melanoma cells prepare sentinel lymph nodes for tumor metastasis","volume":"71","author":"Hood","year":"2011","journal-title":"Cancer Res"},{"issue":"2","key":"10.1016\/j.phrs.2023.106796_bib143","doi-asserted-by":"crossref","first-page":"197","DOI":"10.2217\/rme.13.4","article-title":"Mesenchymal stem cell exosome ameliorates reperfusion injury through proteomic complementation","volume":"8","author":"Lai","year":"2013","journal-title":"Regen. Med"},{"issue":"1","key":"10.1016\/j.phrs.2023.106796_bib144","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1186\/s13287-020-01920-3","article-title":"Functional enhancement strategies for immunomodulation of mesenchymal stem cells and their therapeutic application","volume":"11","author":"Lee","year":"2020","journal-title":"Stem Cell Res Ther."},{"issue":"5","key":"10.1016\/j.phrs.2023.106796_bib145","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1089\/ten.teb.2021.0145","article-title":"Hypoxia-conditioned mesenchymal stem cells in tissue regeneration application","volume":"28","author":"Yang","year":"2022","journal-title":"Tissue Eng. Part B Rev."},{"key":"10.1016\/j.phrs.2023.106796_bib146","article-title":"Adipose-derived mesenchymal stem cells combined with extracellular vesicles may improve amyotrophic lateral sclerosis","volume":"14","author":"Wang","year":"2022","journal-title":"Front Aging Neurosci."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661823001524?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661823001524?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T22:43:29Z","timestamp":1760913809000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661823001524"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":146,"alternative-id":["S1043661823001524"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2023.106796","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"New therapeutic approaches in pediatric diseases: Mesenchymal stromal cell and mesenchymal stromal cell-derived extracellular vesicles as new drugs","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2023.106796","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"106796"}}